{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T20:47:27Z","timestamp":1743108447771,"version":"3.40.3"},"publisher-location":"Cham","reference-count":15,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031723803"},{"type":"electronic","value":"9783031723810"}],"license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In recent years, there has been growing interest in leveraging human preferences for drug discovery to build models that capture chemists\u2019 intuition for <jats:italic>de novo<\/jats:italic> molecular design, lead optimization, and prioritization for experimental validation. However, existing models derived from human preferences in chemistry are often black-boxes, lacking interpretability regarding how humans form their preferences. Enhancing transparency in human-in-the-loop learning is crucial to ensure that such approaches in drug discovery are not unduly affected by subjective bias, noise or inconsistency. Moreover, interpretability can promote the development and use of multi-user models in drug design projects, integrating multiple expert perspectives and insights into multi-objective optimization frameworks for <jats:italic>de novo<\/jats:italic> molecular design. This also allows for assigning more or less weight to experts based on their knowledge of specific properties. In this paper, we present a methodology for decomposing human preferences based on binary responses (like\/dislike) to molecules essentially proposed by generative chemistry models, and inferring interpretable preference models that represent human reasoning. Our approach aims to bridge the gap between human-in-the-loop learning and user model interpretability in drug discovery applications, providing a transparent framework that elucidates how human judgments can shape molecular design outcomes.<\/jats:p>","DOI":"10.1007\/978-3-031-72381-0_6","type":"book-chapter","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T13:10:16Z","timestamp":1726751416000},"page":"58-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Towards Interpretable Models of\u00a0Chemist Preferences for\u00a0Human-in-the-Loop Assisted Drug Discovery"],"prefix":"10.1007","author":[{"given":"Yasmine","family":"Nahal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Heinonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Kabeshov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon Paul","family":"Janet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Nittinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Engkvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Kaski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"6_CR1","unstructured":"RDKit: open-source cheminformatics. https:\/\/www.rdkit.org"},{"key":"6_CR2","doi-asserted-by":"publisher","unstructured":"Bickerton, G.R., Paolini, G.V., Besnard, J., Muresan, S., Hopkins, A.L.: Quantifying the chemical beauty of drugs. Nat. Chem. 4(2), 90\u201398 (2012). https:\/\/doi.org\/10.1038\/NCHEM.1243","DOI":"10.1038\/NCHEM.1243"},{"key":"6_CR3","doi-asserted-by":"crossref","unstructured":"Blaschke, T., et al.: REINVENT 2.0: an AI tool for de novo drug design. J. Chem. Inf. Model. 60(12), 5918\u20135922 (2020)","DOI":"10.1021\/acs.jcim.0c00915"},{"key":"6_CR4","doi-asserted-by":"crossref","unstructured":"Carpenter, B., et al.: Stan: a probabilistic programming language. J. stat. softw. 76(1) (2017)","DOI":"10.18637\/jss.v076.i01"},{"key":"6_CR5","doi-asserted-by":"publisher","unstructured":"Choung, O.H., Vianello, R., Segler, M., Stiefl, N., Jim\u00e9nez-Luna, J.: Learning chemical intuition from humans in the loop. ChemRxiv (2023). https:\/\/doi.org\/10.26434\/chemrxiv-2023-knwnv","DOI":"10.26434\/chemrxiv-2023-knwnv"},{"key":"6_CR6","doi-asserted-by":"publisher","unstructured":"Congreve, M., Carr, R., Murray, C., Jhoti, H.: A \u2018rule of three\u2019 for fragment-based lead discovery? Drug discovery today 8(19), 876\u2013877 (2003). https:\/\/doi.org\/10.1016\/S1359-6446(03)02831-9, https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1359644603028319","DOI":"10.1016\/S1359-6446(03)02831-9"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-1-8","volume":"1","author":"P Ertl","year":"2009","unstructured":"Ertl, P., Schuffenhauer, A.: Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. Journal of cheminformatics 1, 1\u201311 (2009)","journal-title":"Journal of cheminformatics"},{"issue":"1","key":"6_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1140\/epjds\/s13688-019-0201-0","volume":"8","author":"PG Fennell","year":"2019","unstructured":"Fennell, P.G., Zuo, Z., Lerman, K.: Predicting and explaining behavioral data with structured feature space decomposition. EPJ Data Sci. 8(1), 1\u201327 (2019)","journal-title":"EPJ Data Sci."},{"key":"6_CR9","doi-asserted-by":"publisher","unstructured":"Janosch, M., Nahal, Y., Jannik\u00a0Bjerrum, E., Kabeshov, M., Engkvist, O., Kaski, S.: A python-based user interface to collect expert feedback for generative chemistry models. ChemRxiv. 2024; https:\/\/doi.org\/10.26434\/chemrxiv-2024-zs5xp This content is a preprint and has not been peer-reviewed (2024)","DOI":"10.26434\/chemrxiv-2024-zs5xp"},{"issue":"11","key":"6_CR10","doi-asserted-by":"publisher","first-page":"e48476","DOI":"10.1371\/journal.pone.0048476","volume":"7","author":"PS Kutchukian","year":"2012","unstructured":"Kutchukian, P.S., et al.: Inside the mind of a medicinal chemist: the role of human bias in compound prioritization during drug discovery. PLoS ONE 7(11), e48476 (2012)","journal-title":"PLoS ONE"},{"key":"6_CR11","unstructured":"Lundberg, S., Lee, S.I.: A unified approach to interpreting model predictions (2017). https:\/\/arxiv.org\/abs\/1705.07874"},{"key":"6_CR12","doi-asserted-by":"publisher","unstructured":"Maimon, O., Rokach, L.: Improving supervised learning by feature decomposition. In: Eiter, T., Schewe, K.D. (eds.) Foundations of Information and Knowledge Systems, pp. 178\u2013196. Springer, Berlin Heidelberg, Berlin, Heidelberg (2002). https:\/\/doi.org\/10.1007\/3-540-45758-5_12","DOI":"10.1007\/3-540-45758-5_12"},{"key":"6_CR13","doi-asserted-by":"publisher","unstructured":"Olivecrona, M., Blaschke, T., Engkvist, O., Chen, H.: Molecular de-novo design through deep reinforcement learning. J. Cheminformatics 9(1), 48 (2017). https:\/\/doi.org\/10.1186\/s13321-017-0235-x","DOI":"10.1186\/s13321-017-0235-x"},{"key":"6_CR14","unstructured":"Pedregosa, F., et\u00a0al.: SciKit-learn: machine learning in python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011)"},{"key":"6_CR15","doi-asserted-by":"publisher","unstructured":"Sundin, I., et al.: Human-in-the-loop assisted de novo molecular design. J. Cheminformatics 14(1), 86 (2022). https:\/\/doi.org\/10.1186\/s13321-022-00667-8","DOI":"10.1186\/s13321-022-00667-8"}],"container-title":["Lecture Notes in Computer Science","AI in Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-72381-0_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T13:11:37Z","timestamp":1726751497000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-72381-0_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"ISBN":["9783031723803","9783031723810"],"references-count":15,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-72381-0_6","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"20 September 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of Interests"}},{"value":"AIDD","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Workshop on AI in Drug Discovery","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Lugano","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Switzerland","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2024","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"19 September 2024","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"19 September 2024","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"1","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"aidd2024","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/e-nns.org\/wp-content\/uploads\/2024\/ICANN2024-AIDrugDis-CfP_final.pdf","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}